See the DrugPatentWatch profile for cosentyx
Consulting a doctor before lowering the dose of Cosentyx, a medication used to treat several conditions including plaque psoriasis and psoriatic arthritis, is important for several reasons.
Firstly, Cosentyx, also known as secukinumab, has a specific dosage regimen recommended by the manufacturer and medical professionals. This dosage is based on clinical trials and research, which have determined the most effective and safe way to use the drug [1]. Deviating from this recommended dosage, including lowering the dose, can potentially reduce the drug's effectiveness and allow the condition to worsen.
Secondly, lowering the dose without medical consultation can increase the risk of side effects. Cosentyx can have side effects such as cold symptoms, diarrhea, and upper respiratory tract infections [2]. Reducing the dose without a doctor's advice may increase these risks and potentially lead to more severe side effects.
Thirdly, Cosentyx is a biologic drug, which means it is made from living organisms or components of organisms [3]. These types of drugs can have complex interactions with the body's immune system and other medications. Therefore, any changes to the dosage should be made under the guidance of a healthcare professional who understands these interactions.
Lastly, patients may consider lowering the dose to reduce costs, especially if they are paying out of pocket for the medication. However, it's important to note that many insurance companies and patient assistance programs may offer options to help cover the cost of the drug [4]. Consulting a doctor or pharmacist can provide information about these options.
In conclusion, consulting a doctor before lowering the dose of Cosentyx is important to maintain the drug's effectiveness, minimize side effects, understand complex interactions, and explore cost-saving options.
Sources:
[1] "Cosentyx (secukinumab) Injection, for Subcutaneous Use." U.S. Food and Drug Administration, FDA, www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/cosentyx-secukinumab-injection-subcutaneous-use.
[2] "Cosentyx (secukinumab) Injection, for Subcutaneous Use." U.S. Food and Drug Administration, FDA, www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/cosentyx-secukinumab-injection-subcutaneous-use.
[3] "What Are Biologic Medicines?" Food and Drug Administration, FDA, www.fda.gov/drugs/biologics-blood-vaccines-therapeutics/what-are-biologic-medicines.
[4] "Patient Assistance Programs." DrugPatentWatch, 2022, www.drugpatentwatch.com/resources/patient-assistance-programs/.